type here...

Capture

Regulatory Capture

Call for Proposals: 10th Anniversary of the Global Financial Crisis

ProMarket writers
The Initiative on Global Markets (IGM) and the Stigler Center are organizing a conference on the causes, as well as the key players and...
Regulatory Capture

Bribery, Cooperation, and the Evolution of Prosocial Institutions

Michael Muthukrishna
How the science of cooperation and cultural evolution will give us new tools in combating corruption.     There is nothing natural((Putting aside what it means for...
Money in Politics

The Berlusconi Voter, Taken Seriously: a Little Exercise in Historical Comprehension

Giovanni Orsina
The Berlusconi phenomenon in Italy both anticipated and exhibits features that epitomize the plight of Western politics.     This is the third installment of ProMarket’s new article...
Regulatory Capture

Eliot Spitzer: The Democratic Party Has Become the Party of the Status Quo

Guy Rolnik
Former New York governor Eliot Spitzer talks about antitrust, digital platforms, economic concentration, and regulatory capture. Part 2 of 2.      In the first part of...
Money in Politics

The Big Picture: Clientelism, Plutocracy, and Democratization

Francesco Trebbi
Why is the electoral process not enough to rid nations of pathological political distortions such as cronyism and corruption?   This is the second installment of ProMarket’s...
Regulatory Capture

Eliot Spitzer: The U.S. Never Had the Will and the Ability to Hold the Most Powerful to Account

Guy Rolnik
In a special interview with ProMarket, former New York governor Eliot Spitzer talks about financial regulation, regulatory capture, and antitrust. Part 1 of 2.   Clear rules and...
Money in Politics

Populist Plutocrats as a Political Phenomenon

Matthew Stephenson
How can a rich man successfully pose as a representative of the poor and the disenfranchised and become the leader of a populist movement?...
Regulatory Capture

How Biology Explains Back-Scratching Between Wall Street and Government

Cameron K. Murray
The revolving door of government and business explained in the lab. The systemic financial risk-taking in the lead-up to the financial crisis was a product...
Regulatory Capture

"The Pharmaceutical Industry Has a Large Amount of Control Over the Field of Oncology"

Guy Rolnik
In the second part of our two-part interview with Daniel Goldstein, MD, an oncologist who studies the influence of business interests on healthcare, we talk...
Regulatory Capture

When Medical Experiments Serve the Business Needs of Pharmaceutical Firms Instead of Science

Guy Rolnik
The first part of a two-part interview with Daniel Goldstein, MD, an oncologist who also studies the influence of business interests on healthcare—from treating patients...
1...363738...45Page 37 of 45

Latest news

View All

The publication of the Stigler Center at The University of Chicago Booth School of Business

ProMarket is dedicated to discussing how competition tends to be subverted by special interests. The posts represent the opinions of their writers, not necessarily those of the University of Chicago, the Booth School of Business, or its faculty. For more information, please visit ProMarket Policy.